Results 211 to 220 of about 83,236 (262)
Anti-CTLA-4 antibody potentiates the antitumor effect of armed oncolytic virus OVM18 via enhancing intratumoral IL-18R1<sup>+</sup>CD8<sup>+</sup> T cells. [PDF]
Lin X +13 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
CTLA-4 AT-Repeat Polymorphism Reduces the Inhibitory Function of CTLA-4 in Graves' Disease
Thyroid, 2003Graves' disease (GD) is thought to be an autoimmune disease with a strong genetic component. Candidate genes include human leukocyte antigen (HLA) class II genes and CTLA-4. The CTLA-4 gene has a variable length AT-repeat polymorphism in the 3'-untranslated region. We previously found that the AT-repeat of 104 bp or longer was associated with GD.
Masaki, Takara +2 more
openaire +2 more sources
CTLA-4 upregulation during aging
Mechanisms of Ageing and Development, 2002The immune system gradually becomes anergic with age. Here, we measured intracellular levels of cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), a negative regulator of T-cells, in 53 healthy individuals aged 18-94.
Qibin, Leng, Zvi, Bentwich, Gadi, Borkow
openaire +2 more sources
Molecular and Cellular Functions of CTLA-4
2020Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is an inhibitory receptor belonging to the CD28 immunoglobulin subfamily, expressed primarily by T-cells. Its ligands, CD80 and CD86, are typically found on the surface of antigen-presenting cells and can either bind CD28 or CTLA-4, resulting in a costimulatory or a co-inhibitory response ...
Samya, Van Coillie +2 more
openaire +2 more sources
A Native Soluble Form of CTLA-4
Cellular Immunology, 2000CTLA-4 is an immunoregulatory receptor expressed on the surface of activated T and B lymphocytes. The counterreceptors for CTLA-4 are the B7 family molecules. We describe alternatively spliced mRNAs expressed in hematolymphoid tissues of humans, mice, and rats that lack the transmembrane domain coded by exon 3 of the CTLA-4 gene.
Oaks, Martin +5 more
openaire +2 more sources
Current Opinion in Immunology, 1999
The past year has seen significant advances in our understanding of the role of cytotoxic T lymphocyte antigen 4 (CTLA-4) in regulating T cell activation and tolerance. Recent studies indicate that CTLA-4 not only counterbalances CD28 signals but also can inhibit T cell responses independently of CD28. Recent work has also revealed a role for CTLA-4 in
M A, Oosterwegel +4 more
openaire +2 more sources
The past year has seen significant advances in our understanding of the role of cytotoxic T lymphocyte antigen 4 (CTLA-4) in regulating T cell activation and tolerance. Recent studies indicate that CTLA-4 not only counterbalances CD28 signals but also can inhibit T cell responses independently of CD28. Recent work has also revealed a role for CTLA-4 in
M A, Oosterwegel +4 more
openaire +2 more sources
A MOLECULAR PERSPECTIVE OF CTLA-4 FUNCTION
Annual Review of Immunology, 2006Within the paradigm of the two-signal model of lymphocyte activation, the interest in costimulation has witnessed a remarkable emergence in the past few years with the discovery of a large array of molecules that can serve this role, including some with an inhibitory function.
Teft, Wendy A. +2 more
openaire +2 more sources
Soluble CTLA-4 – A confounding factor in CTLA-4 based checkpoint immunotherapy in cancer
Immunology LettersCytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) is a receptor that inhibits the activity of T cells. The CTLA-4 gene consists of four different exons that enable four different isoforms of CTLA-4 to be generated through alternative splicing. Although sCTLA-4 might impede the therapeutic effect of anti-CTLA-4 treatments, the role of sCTLA-4 in the ...
Parviz Azimnasab-sorkhabi +4 more
openaire +2 more sources
Science Translational Medicine, 2014
CTLA-4 blocking antibody induces secondary hypophysitis by binding to CTLA-4 antigen and initiating a type II hypersensitivity reaction.
Shintaro, Iwama +5 more
openaire +2 more sources
CTLA-4 blocking antibody induces secondary hypophysitis by binding to CTLA-4 antigen and initiating a type II hypersensitivity reaction.
Shintaro, Iwama +5 more
openaire +2 more sources

